new psychoactive substances (NPS)

content keywords
The content title Keyword(s)
EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide (furanylfentanyl) new psychoactive substances (NPS) | synthetic drugs
High-risk drug use and new psychoactive substances death | new psychoactive substances (NPS) | problem drug use | recreational drugs | synthetic stimulants
Report on the risk assessment of methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) in the framework of the Council Decision on new psychoactive substances new psychoactive substances (NPS)
EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl) new psychoactive substances (NPS)
New psychoactive substances in Europe: legislation and prosecution — current challenges and solutions law | new psychoactive substances (NPS) | policy
Report on the risk assessment of 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) new psychoactive substances (NPS) | scientific committee
Health responses to new psychoactive substances (Perspectives on Drugs) best practice | emerging topics | harm reduction | health effects | new psychoactive substances (NPS) | treatment
EMCDDA–Europol 2015 Annual Report on the implementation of Council Decision 2005/387/JHA activities | markets | new psychoactive substances (NPS) | policy | seizures | trafficking
EMCDDA–Europol Joint Report on MDMB-CHMICA crime | new psychoactive substances (NPS)
Health responses to new psychoactive substances best practice | emerging topics | health effects | injection | new psychoactive substances (NPS) | prevention | prison | problem drug use | recreational drugs | synthetic drugs | synthetic stimulants | treatment | young people
Loading